comparemela.com

Latest Breaking News On - Business unit consumer goods - Page 4 : comparemela.com

EQS-Adhoc: DKSH Management Ltd : DKSH Reports Strong Full-Year 2021 Results Based on Disciplined Strategy Execution

DKSH Management Ltd. / Key word(s): Annual Results DKSH Reports Strong Full-Year 2021 Results Based on Disciplined Strategy Execution 09-Feb-2022 / 06:59 CET/CEST Release of an ad hoc announcement

DKSH Reports Strong Full-Year 2021 Results Based on Disciplined Strategy Execution

DKSH Management Ltd. / Key word(s): Annual Results DKSH Reports Strong Full-Year 2021 Results Based on Disciplined Strategy Execution 09-Feb-2022 / 06:59 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad ho.

DKSH Holding AG: DKSH Reports Strong Half-Year 2021 Results

DKSH Holding AG: DKSH Reports Strong Half-Year 2021 Results DKSH Reports Strong Half-Year 2021 Results DKSH returns to growth with net sales reaching CHF 5.5 billion (+5.3%) ¹ ¹ Free Cash Flow doubles compared to H1 2020 Key Figures Group (CHF million) H1 2021 1 Constant exchange rates (CER): 2021 figures converted at 2020 exchange rates Zurich, Switzerland, July 15, 2021 - DKSH delivered strong half-year 2021 results. All key figures increased compared to last year such as net sales growing 5.3%, EBIT 20.7%¹ and Free Cash Flow more than doubled. Against the pre-COVID levels of 2019, DKSH reports higher profitability and cash conversion. Business Unit Performance Materials continued its growth track record and, on the back of its transformation, the Fast Moving Consumer Goods business again posted strong EBIT improvements. DKSH also completed four acquisitions and increased eCommerce sales double digit.

IRW-News: NeonMind Biosciences Inc : NeonMind kauft von Psygen Labs synthetisches Psilocybin in pharmazeutischer Qualität für klinische Phase-II-Humanstudie

IRW-News: NeonMind Biosciences Inc : NeonMind kauft von Psygen Labs synthetisches Psilocybin in pharmazeutischer Qualität für klinische Phase-II-Humanstudie
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

DKSH Holding AG: DKSH reports solid 2020 results, strong Free Cash Flow and proposes higher dividend

DKSH Holding AG: DKSH reports solid 2020 results, strong Free Cash Flow and proposes higher dividend Despite COVID-19, DKSH reports key figures broadly stable on last year s level - at CER1 Strong Free Cash Flow of CHF 210.2 million (+34.1%) Assuming an easing of the impact of COVID-19, higher EBIT expected in 2021 Key figures Group(in CHF million) 2020 257.5 2 Excluding restructuring costs in 2019 of CHF 14.5 million 3 Proposal of the Board of Directors Zurich, Switzerland, February 9, 2021 - Despite the COVID-19 pandemic, DKSH reported solid 2020 results. Net sales, EBIT and profit after tax at constant exchange rates broadly matched last year s level. In addition, DKSH increased its Free Cash Flow by 34.1% to CHF 210.2 million and proposed a higher dividend of CHF 1.95 per share (+2.6%). Business Unit Performance Materials expanded its position as a leading specialty chemicals and ingredients distributor and the Fast Moving Consumer Goods business increased profits for

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.